Status:
WITHDRAWN
Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Coronary Artery Disease
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stents are used at centers around the world to unblock the arteries of the heart. These stents are usually made of metal and remain permanently within the blood vessel wall. Newer developments in the ...
Detailed Description
Coronary revascularization by percutaneous coronary intervention (PCI) is the dominant strategy in patients with obstructive coronary artery disease (CAD). Traditionally, PCI is performed with implant...
Eligibility Criteria
Inclusion
- Stable patients with diabetes mellitus
- Two or more stenoses in a major epicardial native coronary artery
- An indication for PCI (i.e. \>70% on angiography or fractional flow reserve (FFR) \<0.8)
- Coronary anatomy suitable for a BVS
Exclusion
- Unwillingness or inability to provide informed consent.
- ST-elevation myocardial infarction
- Hemodynamic instability
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03236415
Start Date
August 1 2017
End Date
July 1 2019
Last Update
October 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.